Total Payments
$3,623
2024 Payments
$424.10
Companies
38
Transactions
225
Medicare Patients
706
Medicare Billing
$30,933
Payment Breakdown by Category
Food & Beverage$3,267 (90.2%)
Education$356.23 (9.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,267 | 196 | 90.2% |
| Education | $356.23 | 29 | 9.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $543.22 | 25 | $0 (2024) |
| ABBVIE INC. | $517.56 | 32 | $0 (2024) |
| PFIZER INC. | $461.32 | 26 | $0 (2024) |
| Amgen Inc. | $331.71 | 19 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $299.82 | 29 | $0 (2020) |
| Duchesnay USA Incorporated | $191.69 | 6 | $0 (2019) |
| Hologic, LLC | $149.20 | 13 | $0 (2022) |
| MAYNE PHARMA COMMERCIAL LLC | $131.33 | 10 | $0 (2023) |
| CooperSurgical, Inc. | $98.04 | 6 | $0 (2022) |
| Exeltis, USA Inc. | $86.79 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $424.10 | 17 | Astellas Pharma US Inc ($177.63) |
| 2023 | $375.54 | 25 | MAYNE PHARMA COMMERCIAL LLC ($131.33) |
| 2022 | $371.14 | 20 | ABBVIE INC. ($94.17) |
| 2021 | $438.88 | 28 | AbbVie Inc. ($192.42) |
| 2020 | $114.52 | 8 | Amgen Inc. ($37.70) |
| 2019 | $427.82 | 29 | AbbVie, Inc. ($85.14) |
| 2018 | $617.84 | 51 | AMAG Pharmaceuticals, Inc. ($170.63) |
| 2017 | $852.95 | 47 | PFIZER INC. ($215.29) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: HORMONE THERAPY | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Biological | ||||||
| 09/25/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Hematology | ||||||
| 08/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: UROLOGY | ||||||
| 08/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Hematology | ||||||
| 08/15/2024 | PFIZER INC. | DUAVEE (Drug), MYFEMBREE | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 07/10/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: VACCINES | ||||||
| 06/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Biological | ||||||
| 05/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: UROLOGY | ||||||
| 04/17/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: VACCINES | ||||||
| 04/03/2024 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 02/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: Biological | ||||||
| 02/21/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Urology | ||||||
| 12/19/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $19.38 | General |
| 11/30/2023 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 11/09/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.10 | General |
| 11/08/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Biological | ||||||
| 10/25/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: WOMENS HEALTH | ||||||
| 10/12/2023 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 10/10/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Biological | ||||||
| 09/14/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 213 | 213 | $19,784 | $8,779 |
| 2022 | 6 | 158 | 158 | $14,294 | $6,705 |
| 2021 | 5 | 152 | 152 | $14,272 | $6,880 |
| 2020 | 6 | 183 | 183 | $16,120 | $8,568 |
Total Patients
706
Total Services
706
Medicare Billing
$30,933
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 39 | 39 | $7,020 | $4,104 | 58.5% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 39 | 39 | $2,730 | $1,723 | 63.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 31 | 31 | $4,650 | $1,003 | 21.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $2,385 | $689.92 | 28.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 43 | 43 | $2,279 | $674.24 | 29.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 16 | 16 | $720.00 | $585.76 | 81.4% |
| 77067 | Screening mammography | Office | 2022 | 26 | 26 | $4,680 | $2,932 | 62.6% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 26 | 26 | $1,820 | $1,222 | 67.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 24 | 24 | $3,600 | $805.45 | 22.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 19 | 19 | $855.00 | $720.02 | 84.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 34 | 34 | $1,802 | $549.23 | 30.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 29 | 29 | $1,537 | $476.75 | 31.0% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 27 | 27 | $4,860 | $3,303 | 68.0% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 27 | 27 | $1,890 | $1,395 | 73.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 24 | 24 | $3,600 | $891.60 | 24.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 39 | 39 | $2,067 | $680.55 | 32.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 35 | 35 | $1,855 | $610.75 | 32.9% |
| 77067 | Mammography of both breasts | Office | 2020 | 32 | 32 | $5,760 | $4,038 | 70.1% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 33 | 33 | $2,310 | $1,709 | 74.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 20 | 20 | $3,000 | $747.60 | 24.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 18 | 18 | $810.00 | $715.58 | 88.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 40 | 40 | $2,120 | $680.12 | 32.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 40 | 40 | $2,120 | $678.76 | 32.0% |
About Dr. Ashley Przybysz, MD
Dr. Ashley Przybysz, MD is a Obstetrics & Gynecology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215984034.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Przybysz, MD has received a total of $3,623 in payments from pharmaceutical and medical device companies, with $424.10 received in 2024. These payments were reported across 225 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,267).
As a Medicare-enrolled provider, Przybysz has provided services to 706 Medicare beneficiaries, totaling 706 services with total Medicare billing of $30,933. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Birmingham, AL
- Active Since 05/27/2006
- Last Updated 10/27/2011
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1215984034
Products in Payments
- LO LOESTRIN FE (Drug) $275.40
- Prolia (Biological) $216.68
- PREMARIN ORALS (Drug) $200.30
- Veozah (Drug) $194.88
- INTRAROSA (Drug) $177.50
- Diclegis (Drug) $166.31
- MYRBETRIQ (Drug) $148.71
- MAKENA (Drug) $138.18
- Myrbetriq (Drug) $97.27
- Orilissa (Drug) $95.89
- MYFEMBREE (Drug) $94.73
- EVENITY (Biological) $91.90
- SLYND (Drug) $86.79
- Saxenda (Drug) $83.36
- ABRYSVO (Biological) $76.09
- Phexxi (Drug) $67.86
- PREMARIN (Drug) $64.70
- Paragard (Device) $59.46
- CONTRAVE (Drug) $53.83
- GEMTESA (Drug) $53.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Birmingham
Dr. Theodore Tsaltas, M.d, M.D
Obstetrics & Gynecology — Payments: $663,738
Obstetrics & Gynecology $663,738
Dr. Tomeka Roberts, Md, MD
Obstetrics & Gynecology — Payments: $43,618
Obstetrics & Gynecology $43,618
William Hudson, Md, MD
Obstetrics & Gynecology — Payments: $42,664
Obstetrics & Gynecology $42,664
Percy Hudson, Md, MD
Obstetrics & Gynecology — Payments: $31,863
Obstetrics & Gynecology $31,863
Brandy Patterson, M.d, M.D
Obstetrics & Gynecology — Payments: $29,561
Obstetrics & Gynecology $29,561
Cynthia Brown, Md, MD
Obstetrics & Gynecology — Payments: $22,131
Obstetrics & Gynecology $22,131